Absolute commitment to long-term value creation for our clients.
As an independent Norwegian portfolio manager we provide our clients with investment opportunities across the Nordic markets and global life science.
"Arctic Asset Management is a specialist in the Nordic markets and in selected global strategies, managing funds and discretionary mandates. We do what it takes to exceed our clients' expectations. That's what we call excellence in execution!"
Lisbeth Gyland, CEO Arctic Asset Management
Arctic Asset Management AS is an independent investment manager. We manage UCITS-funds and discretionary mandates.
At Arctic Asset Management, we have a truly active approach to bringing long-term value creation to our clients.
We are constantly expanding our ambition to be the preferred investment manager for our clients, with long-standing client relationships and continuous growth, thanks to skilled investing.
Arctic Asset Management was founded in 2010, as the investment manager for Arctic Funds Plc. Today we manage both mutual funds and discretionary mandates on behalf of a broad range of Nordic and international clients.
The company is owned by its employees, Arctic Holdings AS and Rasmussengruppen. We are headquartered in Oslo, along with an investment team located in Stockholm.
Arctic Asset Management is licensed by the Financial Supervisory Authority of Norway (Finanstilsynet) to conduct discretionary portfolio management and associated services pursuant to the Securities Trading Act (Lov om Verdipapirhandel).
"Arctic Midt i Måneden" is our mid-month podcast hosted by our CIO, Albert Collett. He invites fund managers and other selected guests to discuss market events, industries and sectors, and investment strategies - among other topics.
Yesterday, Merck announced that it will buy portfolio company Verona Pharma for approximately 10 billion USD. The price of USD 107 per ADS corresponds to a bid premium of 23%. By acquiring Verona, Merck will gain access to its treatment for chronic obstructive pulmonary disease (COPD), a drug which has shown strong launch and sales development.
Juni ble en god børsmåned både ute og hjemme. Oslo Børs nådde sin høyeste notering noensinne; fondsindeksen OSEFX steg med 3,9 % i juni og er opp med 14,7 % så langt i år. Den nordiske VINX indeksen steg med 0,6 % i juni og MSCI World steg med 3,0 % (begge målt i NOK). I USA steg S&P 500 indeksen med 5,0 % målt i dollar.
Teamet har levert sterk aksjeavkastning over tid – i både krevende og skiftende markeder. I denne episoden forteller våre erfarne aksjeforvaltere hvordan de navigerer i en verden preget av støy, skiftende signaler og uro. Sindre Sørbye og Ole Dahl er i studio hos Albert Collett.
Arctic Aurora LifeScience and Arctic Aurora Biotech Select holding Vera Therapeutics increased more than 65% on June 2, upon announcing competitive phase 3 clinical data in IgAN, a severe kidney disorder.
Mai måned viste en sterk utvikling i globale finansmarkeder, preget av økt risikovilje etter turbulensen i april. Verdensindeksen (MSCI World i NOK) steg 5,9 %, mens amerikanske aksjer, representert ved S&P 500 (USD), økte med 6,2 %. Oslo Børs (OSEFX, NOK) hadde også en positiv måned med en oppgang på 5,3 %, drevet av bred sektoroppgang hvor spesielt energi og finans bidro sterkt, mens sektoren defensivt konsum trakk ned, hovedsakelig på grunn av svak utvikling innen lakseoppdrett. Norden (VINX Index, NOK) steg markedet med 2,6 %, hvor industri og finans var de største positive bidragsyterne, mens eiendom bidro negativt.
Sanofi acquires Arctic Aurora LifeScience portfolio company Blueprint Medicines.
On 2 June 2025, the French pharmaceutical company announced its agreement to acquire the Boston-based biotech company Blueprint Medicines in a deal valued at 9.5 billion USD. The acquisition centres on Blueprint's flagship drug, Ayvakit (avapritinib), which is the only approved treatment for advanced systemic mastocytosis in both the EU and the US.
Arctic Asset Management is authorized as an investment firm and is under supervision by the Norwegian Financial Supervisory Authority. The Compliance department seeks to ensure that the company conducts its activities in accordance with applicable laws and standards.
Arctic Asset Management believes strong performance depends on responsible investing. In our view, companies with a positive and improving impact on the environment, corporate governance and social responsibility, are more likely to provide excess returns to investors over time.
We therefore analyse ESG issues and integrate sustainability in our investment process. Furthermore, analysing a company’s ESG factors is a central part of our risk analysis.
Arctic Asset Management
P.O. Box 1833 Vika
NO-0123 Oslo
Haakon VII's gate 5, NO-0161
Tel +47 21 01 31 00
Arctic Asset Management
Sweden Branch
Regeringsgatan 38
SE-111 56 Stockholm
Tel +46 844 68 6100